Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CNTA will rise by +9.06% over the next 2 Weeks and hit $28.57 by Tuesday, March 17, 2026. In that time frame, CNTA's share price is expected to range between $27.50 and $29.62.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 17, 2026 | 27.50 | 28.57 | 29.62 |
| Mar 16, 2026 | 27.46 | 28.41 | 29.40 |
| Mar 13, 2026 | 26.82 | 27.69 | 28.59 |
| Mar 12, 2026 | 26.79 | 27.63 | 28.48 |
| Mar 11, 2026 | 26.70 | 27.54 | 28.32 |
| Mar 10, 2026 | 26.73 | 27.51 | 28.26 |
| Mar 9, 2026 | 26.62 | 27.34 | 28.09 |
| Mar 6, 2026 | 25.90 | 26.62 | 27.31 |
| Mar 5, 2026 | 25.87 | 26.56 | 27.29 |
| Mar 4, 2026 | 25.83 | 26.47 | 27.20 |
CNTA shares rose +1.91% in Wednesday, March 4, 2026's trading session, rising from a previous close of $26.20 to move at $26.70. The stock demonstrated notable intraday movement (see CNTA's key stats for a full breakdown), fluctuating between $26.18 and $27.37, a +4.55% trading range. While recent weeks have seen some volatility, CNTA has managed to secure a +6.63% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.1M shares changing hands, 151.69K more than the previous session. This amounted to $29.27M in total market activity.
Will CNTA Continue Its Upward Trend?
According to analyst ratings and projections for CNTA, Centessa Pharmaceuticals plc shares are anticipated to increase by +9.86%, potentially reaching $29.62 per share by March 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for CNTA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the CNTA stock forecast, now is a good time to buy CNTA stock because its current trading price is -6.56% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CNTA covering social and institutional perspectives.
CNTA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CNTA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 59.30% to 65.16%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 55.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.02%, maintains a neutral outlook for the long term. Insights into CNTA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Centessa Pharmaceuticals Short-Term Forecasts
CNTA Forecast For Next 5 Days
Our algorithm anticipates Centessa Pharmaceuticals (CNTA) stock could hit $25.63 by Mar 11, 2026. This represents a -4.00% rise from today's price, following a +4.09% change over the past five days.
CNTA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Centessa Pharmaceuticals plc (CNTA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $24.93, which would mean a -6.63% decrease from the current price of $26.70. Projections for this period range from a high of $29.21 to a low of $20.93.
CNTA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Centessa Pharmaceuticals's price over the next three months point to a rise. CNTA stock is expected to peak at $29.95 on May 08, 2026 after potentially dipping to $25.04 on Mar 11, 2026. On average, CNTA is likely to trade around $27.37 in the coming 90 days.
Centessa Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Centessa Pharmaceuticals (CNTA) is expected to trade between $25.04 and $34.25 throughout 2026. This would result in an average price of $29.18, potentially offering investors a +9.29% return from current levels.
Centessa Pharmaceuticals plc Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Centessa Pharmaceuticals plc (CNTA) is positioned to show a strong performance in March 2026. The price is predicted to move between $25.04 and $27.86, settling at an average of $26.34. This could translate to a -1.35% loss.
April 2026
Based on current market signals, Centessa Pharmaceuticals plc is projected to trend april 2026. We forecast a trading range from $25.52 to $29.28, with a likely average price of $27.39. Investors could expect a potential return of +2.58%.
May 2026
Our predictive algorithms indicate Centessa Pharmaceuticals plc stock may see a shift in May 2026. The expected range spans $26.75–$29.95, with an average target of $28.23. This represents a positive outlook and a possible gain of +5.73%.
June 2026
Analyzing established trends, Centessa Pharmaceuticals plc looks set to move in June 2026. Projections place the stock between $26.76 and $29.13, averaging around $27.93. This suggests a +4.61% gain from current levels.
July 2026
Market indicators suggest Centessa Pharmaceuticals plc could experience notable changes during July 2026. Prices could fluctuate within $26.75 to $30.28, with a midpoint forecast of $28.72. The stock might deliver a +7.57% gain.
August 2026
Forecasting for August 2026, models estimate that Centessa Pharmaceuticals plc may undergo key fluctuations. If trends hold, the stock might trade between $27.81 and $30.76, averaging $29.15. This signals a positive trajectory with potential returns around +9.18%.
September 2026
According to our latest forecast models, Centessa Pharmaceuticals plc (CNTA) is positioned to show a strong performance in September 2026. The price is predicted to move between $28.32 and $32.29, settling at an average of $30.32. This could translate to a +13.56% gain.
October 2026
Based on current market signals, Centessa Pharmaceuticals plc is projected to trend october 2026. We forecast a trading range from $29.41 to $33.16, with a likely average price of $31.01. Investors could expect a potential return of +16.14%.
November 2026
Our predictive algorithms indicate Centessa Pharmaceuticals plc stock may see a shift in November 2026. The expected range spans $29.36–$34.25, with an average target of $30.79. This represents a positive outlook and a possible gain of +15.32%.
December 2026
Analyzing established trends, Centessa Pharmaceuticals plc looks set to move in December 2026. Projections place the stock between $29.84 and $33.12, averaging around $31.58. This suggests a +18.28% gain from current levels.
January 2027
Market indicators suggest Centessa Pharmaceuticals plc could experience notable changes during January 2027. Prices could fluctuate within $30.65 to $33.29, with a midpoint forecast of $31.97. The stock might deliver a +19.74% gain.
February 2027
Forecasting for February 2027, models estimate that Centessa Pharmaceuticals plc may undergo key fluctuations. If trends hold, the stock might trade between $31.02 and $35.09, averaging $33.17. This signals a positive trajectory with potential returns around +24.23%.
March 2027
According to our latest forecast models, Centessa Pharmaceuticals plc (CNTA) is positioned to show a strong performance in March 2027. The price is predicted to move between $33.30 and $35.56, settling at an average of $34.40. This could translate to a +28.84% gain.
CNTA's history of dividends and stock splits also plays a role in long-term investor confidence.

